Patients with placenta pathology such as praevia, acreta, pre-eclampsia
Patients with bleeding disorders including vonWillebrand disease type I.
Known intolerance to one of the two drugs.
Patients with prolonged QT-time or other serious cardiac diseases.
Liver or kidney failure.
Epilepsy.
Any medical reason why, in the opinion of the investigator, the patient should not participate

NCT02528136_exc_T1
Condition
placenta pathology
NCT02528136_exc_T2
Condition
praevia
NCT02528136_exc_T3
Condition
acreta
NCT02528136_exc_T4
Condition
pre-eclampsia
NCT02528136_exc_T5
Scope
praevia, acreta, pre-eclampsia
NCT02528136_exc_T6
Condition
bleeding disorders
NCT02528136_exc_T7
Condition
vonWillebrand disease type I
NCT02528136_exc_T8
Condition
intolerance
NCT02528136_exc_T9
Multiplier
one of the two
NCT02528136_exc_T10
Drug
drugs
NCT02528136_exc_T11
Condition
prolonged QT-time
NCT02528136_exc_T12
Qualifier
other
NCT02528136_exc_T13
Condition
serious cardiac diseases
NCT02528136_exc_T14
Condition
r or ure.
Ep
NCT02528136_exc_T15
Condition
kidney failure
NCT02528136_exc_T16
Condition
Epilepsy